Diabetes - New-wiki

Novel	Symbols	Name 1	Name 2	Pathways 1 Hide	Pathways 2 Hide	Drugs 1 Hide	Drugs 2 Hide	Diseases 1 Hide	Diseases 2 Hide
Novel Novel	Symbols ANK1 and ITPR3	Name 1 ankyrin 1	Name2 inositol 1,4,5-trisphosphate receptor type 3	Pathway 1 Interaction between L1 and Ankyrins Interaction between L1 and Ankyrins NrCAM interactions CHL1 interactions Neurofascin interactions Neurofascin interactions COPI-mediated anterograde transport	Pathway 2 PLC beta mediated events Effects of PIP2 hydrolysis Elevation of cytosolic Ca2+ levels DAG and IP3 signaling Role of phospholipids in phagocytosis FCERI mediated Ca+2 mobilization Glucagon-like Peptide-1 (GLP1) regulates insulin secretion Ca2+ pathway Regulation of insulin secretion VEGFR2 mediated cell proliferation Ion homeostasis Ion homeostasis CLEC7A (Dectin-1) induces NFAT activation FCGR3A-mediated IL10 synthesis Sensory perception of sweet, bitter, and umami (glutamate) taste Antigen activates B Cell Receptor (BCR) leading to generation of second messengers Antigen activates B Cell Receptor (BCR) leading to generation of second messengers	Drugs 1	Drugs 2 Caffeine	Diseases 1 Hereditary spherocytosis (SPH)	Diseases 2 Type I diabetes mellitus
Novel Novel	Symbols LMO2 and MAPRE3	Name 1 LIM domain only 2	Name2 microtubule associated protein RP/EB family member 3	Pathway 1 RUNX1 regulates transcription of genes involved in differentiation of HSCs	Pathway 2	Drugs 1	Drugs 2	Diseases 1 Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia)	Diseases 2
Novel Novel	Symbols LMO2 and PBX4	Name 1 LIM domain only 2	Name2 PBX homeobox 4	Pathway 1 RUNX1 regulates transcription of genes involved in differentiation of HSCs	Pathway 2	Drugs 1	Drugs 2	Diseases 1 Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia)	Diseases 2
Novel Novel	Symbols LMO2 and KAZN	Name 1 LIM domain only 2	Name2 kazrin, periplakin interacting protein	Pathway 1 RUNX1 regulates transcription of genes involved in differentiation of HSCs	Pathway 2 Formation of the cornified envelope	Drugs 1	Drugs 2	Diseases 1 Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia)	Diseases 2
Novel Novel	Symbols LMO2 and ZNF34	Name 1 LIM domain only 2	Name2 zinc finger protein 34	Pathway 1 RUNX1 regulates transcription of genes involved in differentiation of HSCs	Pathway 2 Generic Transcription Pathway	Drugs 1	Drugs 2	Diseases 1 Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia)	Diseases 2
Novel Novel	Symbols LMO2 and TSEN15	Name 1 LIM domain only 2	Name2 tRNA splicing endonuclease subunit 15	Pathway 1 RUNX1 regulates transcription of genes involved in differentiation of HSCs	Pathway 2 tRNA processing in the nucleus	Drugs 1	Drugs 2	Diseases 1 Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia)	Diseases 2
Novel Novel	Symbols CYTH1 and ARFRP1	Name 1 cytohesin 1	Name2 ARF related protein 1	Pathway 1 Intra-Golgi traffic	Pathway 2 Retrograde transport at the Trans-Golgi-Network Retrograde transport at the Trans-Golgi-Network	Drugs 1	Drugs 2	Diseases 1	Diseases 2
Novel Novel	Symbols CYTH1 and CYTIP	Name 1 cytohesin 1	Name2 cytohesin 1 interacting protein	Pathway 1 Intra-Golgi traffic	Pathway 2	Drugs 1	Drugs 2	Diseases 1	Diseases 2
Novel Novel	Symbols SNRPB and RFX6	Name 1 small nuclear ribonucleoprotein polypeptides B and B1	Name2 regulatory factor X6	Pathway 1 SLBP independent Processing of Histone Pre-mRNAs snRNP Assembly mRNA Splicing - Major Pathway mRNA Splicing - Minor Pathway RNA Polymerase II Transcription Termination SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs SARS-CoV-2 modulates host translation machinery	Pathway 2 Regulation of gene expression in beta cells	Drugs 1	Drugs 2	Diseases 1	Diseases 2
Novel Novel	Symbols SNRPA and SUGP1	Name 1 small nuclear ribonucleoprotein polypeptide A	Name2 SURP and G-patch domain containing 1	Pathway 1 mRNA Splicing - Major Pathway	Pathway 2 mRNA Splicing - Major Pathway	Drugs 1 Malonic acid	Drugs 2	Diseases 1	Diseases 2
Novel Novel	Symbols PDZK1 and FARP2	Name 1 PDZ domain containing 1	Name2 FERM, ARH/RhoGEF and pleckstrin domain protein 2	Pathway 1	Pathway 2 SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion RAC1 GTPase cycle	Drugs 1	Drugs 2	Diseases 1	Diseases 2
Novel Novel	Symbols CLU and TNIK	Name 1 clusterin	Name2 TRAF2 and NCK interacting kinase	Pathway 1 Platelet degranulation Terminal pathway of complement Antimicrobial peptides Regulation of Complement cascade	Pathway 2 Oxidative Stress Induced Senescence	Drugs 1 Zinc Copper Zinc acetate Zinc chloride Zinc sulfate, unspecified form	Drugs 2 Fostamatinib	Diseases 1	Diseases 2
Novel Novel	Symbols CLU and KLF11	Name 1 clusterin	Name2 KLF transcription factor 11	Pathway 1 Platelet degranulation Terminal pathway of complement Antimicrobial peptides Regulation of Complement cascade	Pathway 2	Drugs 1 Zinc Copper Zinc acetate Zinc chloride Zinc sulfate, unspecified form	Drugs 2	Diseases 1	Diseases 2
Novel Novel	Symbols CLU and LRP8	Name 1 clusterin	Name2 LDL receptor related protein 8	Pathway 1 Platelet degranulation Terminal pathway of complement Antimicrobial peptides Regulation of Complement cascade	Pathway 2 Platelet sensitization by LDL Retinoid metabolism and transport	Drugs 1 Zinc Copper Zinc acetate Zinc chloride Zinc sulfate, unspecified form	Drugs 2	Diseases 1	Diseases 2
Novel Novel	Symbols CLU and LEP	Name 1 clusterin	Name2 leptin	Pathway 1 Platelet degranulation Terminal pathway of complement Antimicrobial peptides Regulation of Complement cascade	Pathway 2 Signaling by Leptin Transcriptional regulation of white adipocyte differentiation Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) Synthesis, secretion, and deacylation of Ghrelin	Drugs 1 Zinc Copper Zinc acetate Zinc chloride Zinc sulfate, unspecified form	Drugs 2	Diseases 1	Diseases 2
Novel Novel	Symbols STX1A and STXBP6	Name 1 syntaxin 1A	Name2 syntaxin binding protein 6	Pathway 1 Serotonin Neurotransmitter Release Cycle Norepinephrine Neurotransmitter Release Cycle Glutamate Neurotransmitter Release Cycle Dopamine Neurotransmitter Release Cycle Acetylcholine Neurotransmitter Release Cycle Insulin processing Regulation of insulin secretion Other interleukin signaling Toxicity of botulinum toxin type C (botC) LGI-ADAM interactions Neurexins and neuroligins GABA synthesis, release, reuptake and degradation Insertion of tail-anchored proteins into the endoplasmic reticulum membrane Insertion of tail-anchored proteins into the endoplasmic reticulum membrane Sensory processing of sound by inner hair cells of the cochlea	Pathway 2	Drugs 1	Drugs 2	Diseases 1	Diseases 2
Novel Novel	Symbols TTN and TSC22D2	Name 1 titin	Name2 TSC22 domain family member 2	Pathway 1 Platelet degranulation Striated Muscle Contraction	Pathway 2	Drugs 1	Drugs 2	Diseases 1 Dilated cardiomyopathy (DCM) Distal muscular dystrophies, including: Welander distal myopathy (WDM); Tibial muscular dystrophy (TMD); Nonaka distal myopathy with rimmed vacuoles (DMRV); Miyoshi myopathy (MM); Laing myopathy (MPD1); Distal nebulin myopathy (DNM); Distal desminopathy (MFM1); alpha-B Crystallinopathy (MFM2); Distal myotilinopathy (MFM3); Distal zaspopathy (MFM4); Distal myopathy 3 (MPD2, VCPDM) Hypertrophic cardiomyopathy (HCM)	Diseases 2
Novel Novel	Symbols TTN and MYOM1	Name 1 titin	Name2 myomesin 1	Pathway 1 Platelet degranulation Striated Muscle Contraction	Pathway 2	Drugs 1	Drugs 2	Diseases 1 Dilated cardiomyopathy (DCM) Distal muscular dystrophies, including: Welander distal myopathy (WDM); Tibial muscular dystrophy (TMD); Nonaka distal myopathy with rimmed vacuoles (DMRV); Miyoshi myopathy (MM); Laing myopathy (MPD1); Distal nebulin myopathy (DNM); Distal desminopathy (MFM1); alpha-B Crystallinopathy (MFM2); Distal myotilinopathy (MFM3); Distal zaspopathy (MFM4); Distal myopathy 3 (MPD2, VCPDM) Hypertrophic cardiomyopathy (HCM)	Diseases 2
Novel Novel	Symbols APBB1 and TSHZ2	Name 1 amyloid beta precursor protein binding family B member 1	Name2 teashirt zinc finger homeobox 2	Pathway 1 Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks	Pathway 2	Drugs 1	Drugs 2	Diseases 1	Diseases 2
Novel Novel	Symbols APBB1 and ATM	Name 1 amyloid beta precursor protein binding family B member 1	Name2 ATM serine/threonine kinase	Pathway 1 Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks	Pathway 2 DNA Damage/Telomere Stress Induced Senescence Regulation of HSF1-mediated heat shock response Autodegradation of the E3 ubiquitin ligase COP1 HDR through Single Strand Annealing (SSA) HDR through Homologous Recombination (HRR) Sensing of DNA Double Strand Breaks Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks Resolution of D-loop Structures through Holliday Junction Intermediates Nonhomologous End-Joining (NHEJ) Homologous DNA Pairing and Strand Exchange Processing of DNA double-strand break ends Presynaptic phase of homologous DNA pairing and strand exchange TP53 Regulates Transcription of DNA Repair Genes TP53 Regulates Transcription of Genes Involved in Cytochrome C Release TP53 Regulates Transcription of Caspase Activators and Caspases Regulation of TP53 Activity through Phosphorylation Regulation of TP53 Degradation Regulation of TP53 Activity through Methylation G2/M DNA damage checkpoint Stabilization of p53 Meiotic recombination Pexophagy Defective homologous recombination repair (HRR) due to BRCA1 loss of function Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function Impaired BRCA2 binding to RAD51 Impaired BRCA2 binding to PALB2	Drugs 1	Drugs 2 Caffeine	Diseases 1	Diseases 2 Ataxia telangiectasia (AT); Louis-Bar syndrome; Boder-Sedgwick syndrome Chronic lymphocytic leukemia (CLL) Ataxia with ocular apraxia (AOA), including: Ataxia telangiectasia (AT); Ataxia telangiectasia like disorder (ATLD); Ataxia oculomotor apraxia type 1 (AOA1); Ataxia oculomotor apraxia type 2 (AOA2) DNA repair defects, including the following six diseases: Ataxia telangiectasia (AT); Ataxia-talangiectasia-like syndrome; Nijmegen syndrome; DNA ligase I deficiency; DNA ligase IV deficiency; Bloom's syndrome
Novel	Symbols ANK1 and ITPR3	Name 1 ankyrin 1	Name2 inositol 1,4,5-trisphosphate receptor type 3	Pathway 1 Interaction between L1 and Ankyrins Interaction between L1 and Ankyrins NrCAM interactions CHL1 interactions Neurofascin interactions Neurofascin interactions COPI-mediated anterograde transport	Pathway 2 PLC beta mediated events Effects of PIP2 hydrolysis Elevation of cytosolic Ca2+ levels DAG and IP3 signaling Role of phospholipids in phagocytosis FCERI mediated Ca+2 mobilization Glucagon-like Peptide-1 (GLP1) regulates insulin secretion Ca2+ pathway Regulation of insulin secretion VEGFR2 mediated cell proliferation Ion homeostasis Ion homeostasis CLEC7A (Dectin-1) induces NFAT activation FCGR3A-mediated IL10 synthesis Sensory perception of sweet, bitter, and umami (glutamate) taste Antigen activates B Cell Receptor (BCR) leading to generation of second messengers Antigen activates B Cell Receptor (BCR) leading to generation of second messengers	Drugs 1	Drugs 2 Caffeine	Diseases 1 Hereditary spherocytosis (SPH)	Diseases 2 Type I diabetes mellitus
Novel	Symbols LMO2 and MAPRE3	Name 1 LIM domain only 2	Name2 microtubule associated protein RP/EB family member 3	Pathway 1 RUNX1 regulates transcription of genes involved in differentiation of HSCs	Pathway 2	Drugs 1	Drugs 2	Diseases 1 Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia)	Diseases 2
Novel	Symbols LMO2 and PBX4	Name 1 LIM domain only 2	Name2 PBX homeobox 4	Pathway 1 RUNX1 regulates transcription of genes involved in differentiation of HSCs	Pathway 2	Drugs 1	Drugs 2	Diseases 1 Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia)	Diseases 2
Novel	Symbols LMO2 and KAZN	Name 1 LIM domain only 2	Name2 kazrin, periplakin interacting protein	Pathway 1 RUNX1 regulates transcription of genes involved in differentiation of HSCs	Pathway 2 Formation of the cornified envelope	Drugs 1	Drugs 2	Diseases 1 Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia)	Diseases 2
Novel	Symbols LMO2 and ZNF34	Name 1 LIM domain only 2	Name2 zinc finger protein 34	Pathway 1 RUNX1 regulates transcription of genes involved in differentiation of HSCs	Pathway 2 Generic Transcription Pathway	Drugs 1	Drugs 2	Diseases 1 Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia)	Diseases 2
Novel	Symbols LMO2 and TSEN15	Name 1 LIM domain only 2	Name2 tRNA splicing endonuclease subunit 15	Pathway 1 RUNX1 regulates transcription of genes involved in differentiation of HSCs	Pathway 2 tRNA processing in the nucleus	Drugs 1	Drugs 2	Diseases 1 Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia)	Diseases 2
Novel	Symbols CYTH1 and ARFRP1	Name 1 cytohesin 1	Name2 ARF related protein 1	Pathway 1 Intra-Golgi traffic	Pathway 2 Retrograde transport at the Trans-Golgi-Network Retrograde transport at the Trans-Golgi-Network	Drugs 1	Drugs 2	Diseases 1	Diseases 2
Novel	Symbols CYTH1 and CYTIP	Name 1 cytohesin 1	Name2 cytohesin 1 interacting protein	Pathway 1 Intra-Golgi traffic	Pathway 2	Drugs 1	Drugs 2	Diseases 1	Diseases 2
Novel	Symbols SNRPB and RFX6	Name 1 small nuclear ribonucleoprotein polypeptides B and B1	Name2 regulatory factor X6	Pathway 1 SLBP independent Processing of Histone Pre-mRNAs snRNP Assembly mRNA Splicing - Major Pathway mRNA Splicing - Minor Pathway RNA Polymerase II Transcription Termination SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs SARS-CoV-2 modulates host translation machinery	Pathway 2 Regulation of gene expression in beta cells	Drugs 1	Drugs 2	Diseases 1	Diseases 2
Novel	Symbols SNRPA and SUGP1	Name 1 small nuclear ribonucleoprotein polypeptide A	Name2 SURP and G-patch domain containing 1	Pathway 1 mRNA Splicing - Major Pathway	Pathway 2 mRNA Splicing - Major Pathway	Drugs 1 Malonic acid	Drugs 2	Diseases 1	Diseases 2
Novel	Symbols PDZK1 and FARP2	Name 1 PDZ domain containing 1	Name2 FERM, ARH/RhoGEF and pleckstrin domain protein 2	Pathway 1	Pathway 2 SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion RAC1 GTPase cycle	Drugs 1	Drugs 2	Diseases 1	Diseases 2
Novel	Symbols CLU and TNIK	Name 1 clusterin	Name2 TRAF2 and NCK interacting kinase	Pathway 1 Platelet degranulation Terminal pathway of complement Antimicrobial peptides Regulation of Complement cascade	Pathway 2 Oxidative Stress Induced Senescence	Drugs 1 Zinc Copper Zinc acetate Zinc chloride Zinc sulfate, unspecified form	Drugs 2 Fostamatinib	Diseases 1	Diseases 2
Novel	Symbols CLU and KLF11	Name 1 clusterin	Name2 KLF transcription factor 11	Pathway 1 Platelet degranulation Terminal pathway of complement Antimicrobial peptides Regulation of Complement cascade	Pathway 2	Drugs 1 Zinc Copper Zinc acetate Zinc chloride Zinc sulfate, unspecified form	Drugs 2	Diseases 1	Diseases 2
Novel	Symbols CLU and LRP8	Name 1 clusterin	Name2 LDL receptor related protein 8	Pathway 1 Platelet degranulation Terminal pathway of complement Antimicrobial peptides Regulation of Complement cascade	Pathway 2 Platelet sensitization by LDL Retinoid metabolism and transport	Drugs 1 Zinc Copper Zinc acetate Zinc chloride Zinc sulfate, unspecified form	Drugs 2	Diseases 1	Diseases 2
Novel	Symbols CLU and LEP	Name 1 clusterin	Name2 leptin	Pathway 1 Platelet degranulation Terminal pathway of complement Antimicrobial peptides Regulation of Complement cascade	Pathway 2 Signaling by Leptin Transcriptional regulation of white adipocyte differentiation Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) Synthesis, secretion, and deacylation of Ghrelin	Drugs 1 Zinc Copper Zinc acetate Zinc chloride Zinc sulfate, unspecified form	Drugs 2	Diseases 1	Diseases 2
Novel	Symbols STX1A and STXBP6	Name 1 syntaxin 1A	Name2 syntaxin binding protein 6	Pathway 1 Serotonin Neurotransmitter Release Cycle Norepinephrine Neurotransmitter Release Cycle Glutamate Neurotransmitter Release Cycle Dopamine Neurotransmitter Release Cycle Acetylcholine Neurotransmitter Release Cycle Insulin processing Regulation of insulin secretion Other interleukin signaling Toxicity of botulinum toxin type C (botC) LGI-ADAM interactions Neurexins and neuroligins GABA synthesis, release, reuptake and degradation Insertion of tail-anchored proteins into the endoplasmic reticulum membrane Insertion of tail-anchored proteins into the endoplasmic reticulum membrane Sensory processing of sound by inner hair cells of the cochlea	Pathway 2	Drugs 1	Drugs 2	Diseases 1	Diseases 2
Novel	Symbols TTN and TSC22D2	Name 1 titin	Name2 TSC22 domain family member 2	Pathway 1 Platelet degranulation Striated Muscle Contraction	Pathway 2	Drugs 1	Drugs 2	Diseases 1 Dilated cardiomyopathy (DCM) Distal muscular dystrophies, including: Welander distal myopathy (WDM); Tibial muscular dystrophy (TMD); Nonaka distal myopathy with rimmed vacuoles (DMRV); Miyoshi myopathy (MM); Laing myopathy (MPD1); Distal nebulin myopathy (DNM); Distal desminopathy (MFM1); alpha-B Crystallinopathy (MFM2); Distal myotilinopathy (MFM3); Distal zaspopathy (MFM4); Distal myopathy 3 (MPD2, VCPDM) Hypertrophic cardiomyopathy (HCM)	Diseases 2
Novel	Symbols TTN and MYOM1	Name 1 titin	Name2 myomesin 1	Pathway 1 Platelet degranulation Striated Muscle Contraction	Pathway 2	Drugs 1	Drugs 2	Diseases 1 Dilated cardiomyopathy (DCM) Distal muscular dystrophies, including: Welander distal myopathy (WDM); Tibial muscular dystrophy (TMD); Nonaka distal myopathy with rimmed vacuoles (DMRV); Miyoshi myopathy (MM); Laing myopathy (MPD1); Distal nebulin myopathy (DNM); Distal desminopathy (MFM1); alpha-B Crystallinopathy (MFM2); Distal myotilinopathy (MFM3); Distal zaspopathy (MFM4); Distal myopathy 3 (MPD2, VCPDM) Hypertrophic cardiomyopathy (HCM)	Diseases 2
Novel	Symbols APBB1 and TSHZ2	Name 1 amyloid beta precursor protein binding family B member 1	Name2 teashirt zinc finger homeobox 2	Pathway 1 Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks	Pathway 2	Drugs 1	Drugs 2	Diseases 1	Diseases 2
Novel	Symbols APBB1 and ATM	Name 1 amyloid beta precursor protein binding family B member 1	Name2 ATM serine/threonine kinase	Pathway 1 Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks	Pathway 2 DNA Damage/Telomere Stress Induced Senescence Regulation of HSF1-mediated heat shock response Autodegradation of the E3 ubiquitin ligase COP1 HDR through Single Strand Annealing (SSA) HDR through Homologous Recombination (HRR) Sensing of DNA Double Strand Breaks Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks Resolution of D-loop Structures through Holliday Junction Intermediates Nonhomologous End-Joining (NHEJ) Homologous DNA Pairing and Strand Exchange Processing of DNA double-strand break ends Presynaptic phase of homologous DNA pairing and strand exchange TP53 Regulates Transcription of DNA Repair Genes TP53 Regulates Transcription of Genes Involved in Cytochrome C Release TP53 Regulates Transcription of Caspase Activators and Caspases Regulation of TP53 Activity through Phosphorylation Regulation of TP53 Degradation Regulation of TP53 Activity through Methylation G2/M DNA damage checkpoint Stabilization of p53 Meiotic recombination Pexophagy Defective homologous recombination repair (HRR) due to BRCA1 loss of function Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function Impaired BRCA2 binding to RAD51 Impaired BRCA2 binding to PALB2	Drugs 1	Drugs 2 Caffeine	Diseases 1	Diseases 2 Ataxia telangiectasia (AT); Louis-Bar syndrome; Boder-Sedgwick syndrome Chronic lymphocytic leukemia (CLL) Ataxia with ocular apraxia (AOA), including: Ataxia telangiectasia (AT); Ataxia telangiectasia like disorder (ATLD); Ataxia oculomotor apraxia type 1 (AOA1); Ataxia oculomotor apraxia type 2 (AOA2) DNA repair defects, including the following six diseases: Ataxia telangiectasia (AT); Ataxia-talangiectasia-like syndrome; Nijmegen syndrome; DNA ligase I deficiency; DNA ligase IV deficiency; Bloom's syndrome

Page 30 out of 58 pages

Search Results : Diabetes